Donor Apheresis

PROCEDURE2 trials

Sponsors

David Rizzieri, MD

Conditions

LeukemiaLymphomaMyelodysplasiaMyelomaSolid Tumors

Phase 1

Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT

CompletedNCT00586690

David Rizzieri, MDLymphoma

Start: 2005-05-31End: 2013-11-30Updated: 2017-02-08

Phase 2

Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath

CompletedNCT00580034

David Rizzieri, MDLeukemia, Lymphoma, Myelodysplasia +2

Start: 2003-02-28End: 2013-04-30Updated: 2014-06-03